Skip to main content icon/video/no-internet

Placebo Effect

The placebo effect is a positive change in a person’s symptoms or condition after the administration of an inert substance (e.g., a sugar pill) or an ineffectual procedure (e.g., a teaching method that is not expected to achieve results) administered under the guise of being an effective treatment. Placebo effects have been demonstrated with a variety of medical conditions, including depression, irritable bowel syndrome, pain, asthma, and Parkinson’s disease, as well as occasionally in educational research. The presence and magnitude of the effect is not constant across situations; rather, it varies as a function of disease condition, type of outcome, and method of administration. Although symptoms under conscious awareness are often susceptible to a placebo effect, objective disease markers, such as blood sugar levels, are typically less amenable. Additionally, individual characteristics, such as age, personality, level of optimism, previous treatment experience, and presence of psychopathology, have all been found to influence the likelihood of a placebo response.

Mechanism

The placebo effect can be explained by two psychological theories: expectancy and classical conditioning. Research indicates that expectancy strongly influences the effect of a placebo response, and the response can be enhanced with verbal messages emphasizing that a positive change in symptoms should be anticipated. Classical conditioning theory has also been applied, and related research has found that placebos can effectively alleviate pain even after subjects are alerted to the fact that they are not receiving actual treatment, so long as the association between the placebo and analgesia has been well conditioned. The placebo effect, while psychologically mediated, has been found to affect neurobiological as well as cognitive processes. For example, increases in striatal dopamine and endogenous opioids in Parkinson’s disease and pain patients, respectively, have been demonstrated following administration of a placebo.

Implications

Medical practitioners have been aware of the placebo effect for centuries, and knowledge of the phenomenon has become well incorporated in medical research. Because of the placebo effect, as well as the impacts of natural recovery and regression toward the mean, randomized controlled trials have become the gold standard for researching new drugs. In randomized controlled trials, participants are randomly assigned to either a treatment or a control group, with control participants often receiving a placebo. Ideally, assignment is double-blind, meaning that neither the participants nor the researchers are aware of who is receiving the placebo versus actual treatment. The treatment under investigation must then evidence incremental benefit above and beyond the placebo to demonstrate that any measured improvement is not an artifact of the placebo effect. Such a requirement poses a challenge for researchers investigating treatments for certain conditions such as depression, where the placebo effect is often quite high. Given the significance of the phenomenon, recent research has begun to investigate how lessons learned from the placebo effect can be harnessed by medical providers and clinically applied.

See also Classical Conditioning; Double-Blind Design; Hawthorne Effect; Random Assignment; Regression Toward the Mean

Phillip K. Martin Ryan W. Schroeder
10.4135/9781506326139.n521

Further Readings

Benedetti, F., Enck, P., Frisaldi, E.,

...

  • Loading...
locked icon

Sign in to access this content

Get a 30 day FREE TRIAL

  • Watch videos from a variety of sources bringing classroom topics to life
  • Read modern, diverse business cases
  • Explore hundreds of books and reference titles

Sage Recommends

We found other relevant content for you on other Sage platforms.

Loading